Avatar
Yahoo Sports News source @sports.yahoo.com · Playa Vista, Los Angeles 🇺🇸· 3w

#Pharmaceuticals #DrugDevelopment #HealthcareInnovation

Link Preview
sports.yahoo.com
The hidden infrastructure behind every prescription drug in 2026
The hidden infrastructure behind every prescription drug in 2026 A customer steps up to the counter at a neighborhood pharmacy.
Avatar
Harvard Gazette News source @news.harvard.edu · 4w

#CancerResearch #DrugDevelopment #ProteinBiology

Link Preview
news.harvard.edu
Unlocking hidden pocket on a billion‑dollar drug target -- Harvard Gazette
Scientists identify path toward making cancer drugs safer and more selective For years, a protein inside our cells has quietly powered billions of dollars' worth of cancer drugs.
Avatar
Forbes News source @forbes.com · Jersey City, New Jersey 🇯🇪· Feb 13

#Neuropsychiatry #DrugDevelopment #MentalHealth

Link Preview
www.forbes.com
Startup Organotics Fast Tracks Personalized Brain Drug Trials
Psychiatric drug development has a sobering statistic: nearly 96% of neuropsychiatric drugs fail, including many aimed at autism, bipolar disorder, and schizophrenia.
Avatar
NASDAQ Stock Market News source @nasdaq.com · New York City 🇺🇸· Jan 5

#Pharmaceuticals #ClinicalTrials #DrugDevelopment

Link Preview
www.nasdaq.com
Crinetics To Provide Update On PALSONIFY And Topline Results From Phase 2 Trial Of Atumelnant In CAH
(RTTNews) - Crinetics Pharmaceuticals, Inc. (CRNX) is scheduled to host a conference call to provide an update on its lead drug PALSONIFY's commercialisation and disclose topline results from the fourth cohort of its Phase 2 trial of Atumelnant in congenital adrenal hyperplasia or CAH, today.
Avatar
Seeking Alpha News source @seekingalpha.com · Jan 4

#Biotech #DrugDevelopment #Investing

Link Preview
seekingalpha.com
GH Research: GH001 Shows Robust Data Ahead Of FDA IND Decision (NASDAQ:GHRS)
A positive IND outcome could catalyze further upside, but current valuation reflects significant optimism already priced in.